Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29623938 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2POLBMCL1HPGDALOX15 | |
| SCHEMBL3394147 | 0.85 | MAPK1 (0.57) | SMN1; SMN2MCL1TDP1RAB9ANPC1 | |
| SCHEMBL1186765 | 0.80 | SMN1; SMN2 (0.71) | SMN1; SMN2POLBHPGDALOX15TDP1 | |
| SCHEMBL5247667 | 0.80 | SMN1; SMN2 (0.71) | SMN1; SMN2POLBHPGDALOX15TDP1 | |
| SCHEMBL20105000 | 0.80 | MCL1 (0.50) | SMN1; SMN2POLBMCL1HPGDALOX15 | |
| SCHEMBL29493662 | 0.80 | MCL1 (0.50) | SMN1; SMN2POLBMCL1HPGDALOX15 | |
| SCHEMBL9773 | 0.79 | SMN1; SMN2 (0.69) | SMN1; SMN2POLBHPGDALOX15TDP1 | |
| SCHEMBL3841381 | 0.79 | SMN1; SMN2 (0.69) | SMN1; SMN2POLBHPGDALOX15TDP1 | |
| SCHEMBL1186533 | 0.79 | SMN1; SMN2 (0.69) | SMN1; SMN2POLBHPGDALOX15TDP1 | |
| SCHEMBL30585275 | 0.79 | SMN1; SMN2 (0.69) | SMN1; SMN2POLBHPGDALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12020872-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | Ambient Photonics, Inc. (US) | 2024-06-25 | — | — | US | disclosed |
| EP-3621957-B1 | FUSED STILBENE DERIVATIVES AS SOLAR CELL DYES | AMBIENT PHOTONICS INC (US) | 2023-08-23 | — | — | EP | disclosed |
| EP-3621957-B1 | FUSED STILBENE DERIVATIVES AS SOLAR CELL DYES | AMBIENT PHOTONICS INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11664171-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | Ambient Photonics, Inc. (US) | 2023-05-30 | — | — | US | disclosed |
| US-11664171-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | Ambient Photonics, Inc. (US) | 2023-05-30 | — | — | US | disclosed |
| US-20230154691-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | Ambient Photonics, Inc. (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230154691-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | Ambient Photonics, Inc. (US) | 2023-05-18 | — | — | US | disclosed |
| EP-3374354-B1 | BENZOFURAN DERIVATIVES FOR THE TREATMENT OF CNS AND OTHER DISORDERS | AMBIENT PHOTONICS INC (US) | 2022-09-28 | — | — | EP | disclosed |
| CN-108699019-B | Benzofuran derivatives useful in the treatment of central nervous system and other diseases | 华纳巴布科克绿色化学学院有限公司 | 2022-05-10 | — | — | CN | disclosed |
| US-20210082632-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | Ambient Photonics, Inc. (US) | 2021-03-18 | — | — | US | disclosed |
| US-20180346433-A1 | BENZOFURAN DERIVATIVES FOR THE TREATMENT OF CNS AND OTHER DISORDERS | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2018-12-06 | — | — | US | disclosed |
| WO-2018208712-A1 | STILBENE AND FUSED STILBENE DERIVATIVES AS SOLAR CELL DYES | WARNER BABCOCK INSITUTE FOR GREEN CHEMISTRY, LLC (US) | 2018-11-15 | — | — | WO | disclosed |
| EP-3374354-A1 | BENZOFURAN DERIVATIVES FOR THE TREATMENT OF CNS AND OTHER DISORDERS | The Warner-Babcock Institute For Green Chemistry LLC (US) | 2018-09-19 | — | — | EP | disclosed |
| WO-2017083488-A1 | BENZOFURAN DERIVATIVES FOR THE TREATMENT OF CNS AND OTHER DISORDERS | Warner Babcock Institute for Green Chemistry (US) | 2017-05-18 | — | — | WO | disclosed |
| WO-2017083488-A1 | BENZOFURAN DERIVATIVES FOR THE TREATMENT OF CNS AND OTHER DISORDERS | Warner Babcock Institute for Green Chemistry (US) | 2017-05-18 | — | — | WO | disclosed |
| US-6174877-B1 | EXCELLANT BACTERICIDES, ORAL ABSORBABILITY AND STABILITY; IMPROVE THE STABILITY TO RENAL DEHYDROPEPTIDASE I (DHP-I); 2-(2-(N-HETEROCYCLIC-ETHYLTHIO-) DERIVATIVES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-0876370-A1 | CARBAPENEM COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997025325-A1 | CARBAPENEM COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-07-17 | — | — | WO | disclosed |
| US-4435407-A | ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS; IMMUNOMODULATORS | CIBA-GEIGY CORPORATION (US) | 1984-03-06 | — | — | US | disclosed |
| US-4361567-A | IMIDAZO(1,5-A)PYRIDINES | SCHERING CORPORATION (US) | 1982-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12020872-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | FDFT1, SUN2, CDC73 | SMN1; SMN2 4396/4885POLB 2694/4885MCL1 1804/4885 |
| US-20230154691-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | FDFT1, SUN2, CDC73 | SMN1; SMN2 4396/4885POLB 2694/4885MCL1 1804/4885 |
| US-20180346433-A1 | BENZOFURAN DERIVATIVES FOR THE TREATMENT OF CNS AND OTHER DISORDERS | PMP22, CDR2, CLN6 | SMN1; SMN2 27/4885POLB 4080/4885MCL1 3129/4885 |
| US-11664171-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | SUN2, FDFT1, SIK1 | SMN1; SMN2 4215/4885POLB 2611/4885MCL1 1991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.